| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
Form 4: Rothblatt Martine A, Director
Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.64M) |
| 12 Nov 2026 |
Form 4: Rothblatt Martine A, Director
Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.64M) |
| 12 Nov 2026 |
Form 4: Rothblatt Martine A, Director
Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.57M) |
| 10 Nov 2026 |
Form 4: Rothblatt Martine A, Director
Sold 1,614 shares ($944K) |
| 10 Nov 2026 |
Form 4: Rothblatt Martine A, Director
Received 9,500 shares by exercise or conversion ($1.12M) · Sold 7,886 shares ($4.52M) |
| 10 Nov 2026 |
Form 4: Patusky Christopher, Director
Received 1,210 shares by exercise or conversion ($160K) · Sold 1,210 shares ($702K) |
| 09 Nov 2026 |
Form 4: Rothblatt Martine A, Director
Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.36M) |
| 09 Nov 2026 | 144 |
| 06 Nov 2026 |
Form 4: Rothblatt Martine A, Director
Sold 1,960 shares ($1.17M) |
| 06 Nov 2026 |
Form 4: Rothblatt Martine A, Director
Received 9,500 shares by exercise or conversion ($1.12M) · Sold 7,540 shares ($4.33M) |
| 05 Nov 2026 |
Form 4: Rothblatt Martine A, Director
Sold 1,723 shares ($1.05M) |
| 05 Nov 2026 |
Form 4: Rothblatt Martine A, Director
Received 9,500 shares by exercise or conversion ($1.12M) · Sold 7,777 shares ($4.66M) |
| 05 Nov 2026 |
Form 4: Mahon Paul A, EVP & GENERAL COUNSEL
Received 8,300 shares by exercise or conversion ($1.21M) · Sold 8,300 shares ($4.97M) |
| 05 Nov 2026 | 144 |
| 04 Nov 2026 | SCHEDULE 13G/A |
| 04 Nov 2026 |
Form 4: Rothblatt Martine A, Director
Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.72M) |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., November 4, 2026: United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended September 30, 2026. Total re... |
| 04 Nov 2026 | 10-Q |
| 03 Nov 2026 |
Form 4: Rothblatt Martine A, Director
Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.66M) |
| 02 Nov 2026 | 144 |
Loading...